Abuchar-Duque MJ, Tapias-Sirosi LC, Ruiz-Manco D, Ramírez-Moreno Ó, Prieto-Rivera JA

Language: Spanish
References: 29
Page: 157-165
PDF size: 729.53 Kb.

ABSTRACT

Introduction: Sudden sensorineural hearing loss (SSHL) affects thousands of people worldwide, causing disability and reduced quality of life in adults of working age. It is an otologic emergency requiring prompt intervention to prevent permanent hearing loss. Despite various global treatment protocols, no consensus exists regarding the most effective approach. Materials and methods: This descriptive, observational, cross-sectional study included 92 patients diagnosed with SSHL at Hospital Universitario Clínica San Rafael between 2018 and 2022. A protocol of serial intratympanic dexamethasone injections was implemented over three consecutive weeks, within 15 days of symptom onset. A retrospective analysis assessed hearing gain. Results: A polynomial correlation (R^² = 0.046) indicated a trend toward greater hearing gains in patients treated earlier. After adjusting the raw data by excluding poor prognosis variables such as advanced age and cardiovascular comorbidities, the trend toward improved outcomes with earlier treatment initiation remained consistent. Discussio: Hearing gain was greater in patients under 65 years old, without comorbidities, and treated earlier. The variability in recovery highlights the influence of multiple prognostic factors and underscores the need for randomized controlled trials to clarify treatment efficacy. Conclusions: SSHL has a variable prognosis influenced by multiple factors. However, patients who receive early intratympanic corticosteroid therapy demonstrate better hearing recovery than those treated later, supporting its role as an effective treatment option in selected cases.

REFERENCES

1. Chandrasekhar SS, Tsai Do BS, Schwartz SR, Bontempo LJ,Faucett EA, Finestone SA, et al. Clinical Practice Guideline:Sudden Hearing Loss (Update). Otolaryngol Head Neck Surg. 2019;161(1_suppl):S1-S45. doi: 10.1177/0194599819859885

2. Singh A, Kumar Irugu DV. Sudden sensorineural hearingloss - A contemporary review of management issues. J Otol.2020;15(2):67-73. doi: 10.1016/j.joto.2019.07.001

3. Alexander TH, Harris JP. Incidence of sudden sensorineuralhearing loss. Otol Neurotol. 2013;34(9):1586-9. doi: 10.1097/MAO.0000000000000222

4. Klemm E, Deutscher A, Mösges R. Aktuelle Stichprobezur Epidemiologie des idiopathischen Hörsturzes.Laryngorhinootologie. 2009;88(8):524-7. doi: 10.1055/s-0028-1128133

5. Khater A, El-Anwar MW, Nofal AA, Elbahrawy AT.Sudden Sensorineural Hearing Loss: Comparative Study ofDifferent Treatment Modalities. Int Arch Otorhinolaryngol.2018;22(3):245-249. doi: 10.1055/s-0037-1605376

6. Fetterman BL, Luxford WM, Saunders JE. Sudden bilateralsensorineural hearing loss. Laryngoscope. 1996;106(11):1347-50. doi: 10.1097/00005537-199611000-00008

7. Ni W, Song SP, Jiang YD. Association between routinehematological parameters and sudden sensorineural hearingloss: A meta-analysis. J Otol. 2021;16(1):47-54. doi: 10.1016/j.joto.2020.07.006

8. Lam M, Bao Y, Hua GB, Sommer DD. Sudden SensorineuralHearing Loss and Metabolic Syndrome: A Systematic Reviewand Meta-analysis. Otol Neurotol. 2021;42(9):1308-1313. doi:10.1097/MAO.0000000000003302

9. El Sabbagh NG, Sewitch MJ, Bezdjian A, Daniel SJ.Intratympanic dexamethasone in sudden sensorineural hearingloss: A systematic review and meta-analysis. Laryngoscope.2017;127(8):1897-1908. doi: 10.1002/lary.26394

10. Sajid T, Ali SM, Shah MI, Hussain A, Zaman A, Qamar NaqviSR, et al. Oral Corticosteroid Therapy For Sudden SensorineuralHearing Loss And Factors Affecting Prognosis. J Ayub MedColl Abbottabad. 2021;33(2):279-282.

11. Kakehata S, Sasaki A, Futai K, Kitani R, Shinkawa H. Dailyshort-term intratympanic dexamethasone treatment alone as aninitial or salvage treatment for idiopathic sudden sensorineuralhearing loss. Audiol Neurootol. 2011;16(3):191-7. doi:10.1159/000320269

12. Bear ZW, Mikulec AA. Intratympanic steroid therapy fortreatment of idiopathic sudden sensorineural hearing loss. MoMed. 2014;111(4):352-6.

13. Lyu Y, Zeng F, Yan M, Zhou Z, Zhang W, Liu M, et al.Comparison of 2 Different Intratympanic MethylprednisoloneInjection Schedules in Combination With IntravenousDexamethasone for Unilateral Sudden Sensorineural HearingLoss. Ear Nose Throat J. 2021;100(3):309S-316S. doi:10.1177/0145561320904816

14. Jin MC, Qian ZJ, Cooperman SP, Alyono JC. Trends in Use andTiming of Intratympanic Corticosteroid Injections for SuddenSensorineural Hearing Loss. Otolaryngol Head Neck Surg.2021;165(1):166-173. doi: 10.1177/0194599820976177

15. Formeister EJ, Chien W, Agrawal Y, Carey JP, Stewart CM, SunDQ. Preliminary Analysis of Association Between COVID-19Vaccination and Sudden Hearing Loss Using US Centers forDisease Control and Prevention Vaccine Adverse EventsReporting System Data. JAMA Otolaryngol Head Neck Surg.2021;147(7):674-676. doi: 10.1001/jamaoto.2021.0869

16. Mirian C, Ovesen T. Intratympanic vs Systemic Corticosteroidsin First-line Treatment of Idiopathic Sudden SensorineuralHearing Loss: A Systematic Review and Meta-analysis. JAMAOtolaryngol Head Neck Surg. 2020;146(5):421-428. doi:10.1001/jamaoto.2020.0047

17. Jung WW, Hoegerl C. Sudden Sensorineural Hearing Lossand Why It’s an Emergency. Cureus. 2022;14(1):e21418. doi:10.7759/cureus.21418

18. Chien CY, Tai SY, Wang LF, Hsi E, Chang NC, Wu MT,et al. Metabolic Syndrome Increases the Risk of SuddenSensorineural Hearing Loss in Taiwan: A Case-Control Study.Otolaryngol Head Neck Surg. 2015;153(1):105-11. doi:10.1177/0194599815575713

19. Prince ADP, Stucken EZ. Sudden Sensorineural Hearing Loss:A Diagnostic and Therapeutic Emergency. J Am Board FamMed. 2021;34(1):216-223. doi: 10.3122/jabfm.2021.01.200199

20. Benito-Orejas JS, Ramírez-Salas JE, Mena-Domínguez EA,Duque-Holguera V, Muñoz-Moreno MF, Santos-Pérez J.Sordera súbita idiopática: factores pronósticos y resultadosdel tratamiento de rescate con dexametasona intratimpánica.Revista ORL. 2023;14(1):9-24. doi: 10.14201/orl.29939

21. Carrier DA, Arriaga MA. Cost-Effective Evaluation ofAsymmetric Sensorineural Hearing Loss with FocusedMagnetic Resonance Imaging. Otolaryngol Head Neck Surg.1997;116(6):567-574. doi: 10.1016/S0194-5998(97)70229-8

22. Ramos HV, Barros FA, Yamashita H, Penido Nde O, SouzaAC, Yamaoka WY. Magnetic resonance imaging in suddendeafness. Braz J Otorhinolaryngol. 2005;71(4):422-6. doi:10.1016/s1808-8694(15)31193-9

23. Nosrati-Zarenoe R, Hultcrantz E. Corticosteroid treatment ofidiopathic sudden sensorineural hearing loss: randomized tripleblindplacebo-controlled trial. Otol Neurotol. 2012;33(4):523-31. doi: 10.1097/MAO.0b013e31824b78da

24. Liebau A, Pogorzelski O, Salt AN, Plontke SK. Hearing ChangesAfter Intratympanically Applied Steroids for Primary Therapyof Sudden Hearing Loss: A Meta-analysis Using MathematicalSimulations of Drug Delivery Protocols. Otol Neurotol.2017;38(1):19-30. doi: 10.1097/MAO.0000000000001254

25. Sung HK, Kang JC, Shin KH, An YS. Comparison of theEffects of Intratympanic Steroid Injection at DifferentIntervals in Sudden Sensorineural Hearing Loss. J Audiol Otol.2020;24(1):24-28. doi: 10.7874/jao.2019.00318

26. Wood JW, Shaffer AD, Kitsko D, Chi DH. Sudden SensorineuralHearing Loss in Children-Management and Outcomes: A Metaanalysis.Laryngoscope. 2021;131(2):425-434. doi: 10.1002/lary.28829

27. Tripathi P, Deshmukh P. Sudden Sensorineural HearingLoss: A Review. Cureus. 2022;14(9):e29458. doi: 10.7759/cureus.29458

28. Byl FM Jr. Sudden hearing loss: eight years’ experience andsuggested prognostic table. Laryngoscope. 1984;94(5):647-61.

29. Tsounis M, Psillas G, Tsalighopoulos M, Vital V, MaroudiasN, Markou K. Systemic, intratympanic and combinedadministration of steroids for sudden hearing loss. A prospectiverandomized multicenter trial. Eur Arch Otorhinolaryngol.2018;275(1):103-110. doi: 10.1007/s00405-017-4803-5